rs149030303

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_024301.5(FKRP):​c.249C>T​(p.Ala83Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0129 in 1,582,434 control chromosomes in the GnomAD database, including 174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 16 hom., cov: 33)
Exomes 𝑓: 0.013 ( 158 hom. )

Consequence

FKRP
NM_024301.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -2.99

Publications

6 publications found
Variant links:
Genes affected
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
FKRP Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2I
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy type B5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
  • myopathy caused by variation in FKRP
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 19-46755699-C-T is Benign according to our data. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-46755699-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 96107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00925 (1409/152330) while in subpopulation SAS AF = 0.0186 (90/4828). AF 95% confidence interval is 0.0155. There are 16 homozygotes in GnomAd4. There are 697 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FKRPNM_024301.5 linkc.249C>T p.Ala83Ala synonymous_variant Exon 4 of 4 ENST00000318584.10 NP_077277.1 Q9H9S5A0A024R0R7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FKRPENST00000318584.10 linkc.249C>T p.Ala83Ala synonymous_variant Exon 4 of 4 1 NM_024301.5 ENSP00000326570.4 Q9H9S5

Frequencies

GnomAD3 genomes
AF:
0.00929
AC:
1414
AN:
152212
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00253
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00406
Gnomad ASJ
AF:
0.0110
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0192
Gnomad FIN
AF:
0.0156
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0135
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.0107
AC:
2147
AN:
200206
AF XY:
0.0118
show subpopulations
Gnomad AFR exome
AF:
0.00247
Gnomad AMR exome
AF:
0.00231
Gnomad ASJ exome
AF:
0.0119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0149
Gnomad NFE exome
AF:
0.0143
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.0133
AC:
19023
AN:
1430104
Hom.:
158
Cov.:
33
AF XY:
0.0136
AC XY:
9678
AN XY:
710616
show subpopulations
African (AFR)
AF:
0.00222
AC:
73
AN:
32878
American (AMR)
AF:
0.00230
AC:
100
AN:
43570
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
298
AN:
25678
East Asian (EAS)
AF:
0.0000261
AC:
1
AN:
38344
South Asian (SAS)
AF:
0.0179
AC:
1500
AN:
83892
European-Finnish (FIN)
AF:
0.0136
AC:
513
AN:
37806
Middle Eastern (MID)
AF:
0.0195
AC:
112
AN:
5734
European-Non Finnish (NFE)
AF:
0.0143
AC:
15780
AN:
1102844
Other (OTH)
AF:
0.0109
AC:
646
AN:
59358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1180
2359
3539
4718
5898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00925
AC:
1409
AN:
152330
Hom.:
16
Cov.:
33
AF XY:
0.00936
AC XY:
697
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00252
AC:
105
AN:
41588
American (AMR)
AF:
0.00405
AC:
62
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
38
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0186
AC:
90
AN:
4828
European-Finnish (FIN)
AF:
0.0156
AC:
166
AN:
10628
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0135
AC:
921
AN:
68008
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
77
153
230
306
383
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0118
Hom.:
5
Bravo
AF:
0.00767
Asia WGS
AF:
0.00953
AC:
33
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala83Ala in exon 4 of FKRP: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 1.3% (115/8570) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs149030303). -

May 12, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 15, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 17, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 30, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 19, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;C4284790:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 Benign:1
Aug 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2I Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jan 25, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Walker-Warburg congenital muscular dystrophy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
1.7
DANN
Benign
0.92
PhyloP100
-3.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149030303; hg19: chr19-47258956; COSMIC: COSV106059521; COSMIC: COSV106059521; API